nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP3A4—Temozolomide—brain cancer	0.238	0.344	CbGbCtD
Sitagliptin—CYP3A4—Lomustine—brain cancer	0.202	0.293	CbGbCtD
Sitagliptin—CYP2C8—Etoposide—brain cancer	0.12	0.174	CbGbCtD
Sitagliptin—ABCB1—Etoposide—brain cancer	0.0815	0.118	CbGbCtD
Sitagliptin—CYP3A4—Etoposide—brain cancer	0.0488	0.0707	CbGbCtD
Sitagliptin—Contusion—Lomustine—brain cancer	0.00817	0.0266	CcSEcCtD
Sitagliptin—Osteoarthritis—Lomustine—brain cancer	0.00517	0.0168	CcSEcCtD
Sitagliptin—Parosmia—Temozolomide—brain cancer	0.00422	0.0137	CcSEcCtD
Sitagliptin—Renal failure—Lomustine—brain cancer	0.00392	0.0128	CcSEcCtD
Sitagliptin—Lung disorder—Temozolomide—brain cancer	0.00386	0.0126	CcSEcCtD
Sitagliptin—Herpes zoster—Temozolomide—brain cancer	0.00363	0.0118	CcSEcCtD
Sitagliptin—Infection—Carboplatin—brain cancer	0.00289	0.0094	CcSEcCtD
Sitagliptin—Neck pain—Carmustine—brain cancer	0.00286	0.00933	CcSEcCtD
Sitagliptin—Pancreatitis—Procarbazine—brain cancer	0.00278	0.00906	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Temozolomide—brain cancer	0.00277	0.00901	CcSEcCtD
Sitagliptin—Renal failure acute—Hydroxyurea—brain cancer	0.00275	0.00896	CcSEcCtD
Sitagliptin—Pneumonia—Procarbazine—brain cancer	0.00254	0.00829	CcSEcCtD
Sitagliptin—Infection—Lomustine—brain cancer	0.00253	0.00822	CcSEcCtD
Sitagliptin—Pain—Carboplatin—brain cancer	0.00248	0.00809	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Procarbazine—brain cancer	0.00248	0.00808	CcSEcCtD
Sitagliptin—Face oedema—Hydroxyurea—brain cancer	0.00245	0.00799	CcSEcCtD
Sitagliptin—Cellulitis—Etoposide—brain cancer	0.00241	0.00784	CcSEcCtD
Sitagliptin—Blood creatinine increased—Hydroxyurea—brain cancer	0.00238	0.00775	CcSEcCtD
Sitagliptin—Breast disorder—Hydroxyurea—brain cancer	0.0023	0.00748	CcSEcCtD
Sitagliptin—Gastroenteritis—Temozolomide—brain cancer	0.00224	0.00729	CcSEcCtD
Sitagliptin—Decreased appetite—Lomustine—brain cancer	0.00221	0.0072	CcSEcCtD
Sitagliptin—Pancreatitis—Hydroxyurea—brain cancer	0.00215	0.00701	CcSEcCtD
Sitagliptin—Weight increased—Hydroxyurea—brain cancer	0.002	0.00651	CcSEcCtD
Sitagliptin—Face oedema—Carmustine—brain cancer	0.00198	0.00646	CcSEcCtD
Sitagliptin—Infestation—Hydroxyurea—brain cancer	0.00196	0.00638	CcSEcCtD
Sitagliptin—Infestation NOS—Hydroxyurea—brain cancer	0.00196	0.00638	CcSEcCtD
Sitagliptin—Tension—Procarbazine—brain cancer	0.00194	0.00632	CcSEcCtD
Sitagliptin—Nervousness—Procarbazine—brain cancer	0.00192	0.00625	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00192	0.00625	CcSEcCtD
Sitagliptin—Face oedema—Temozolomide—brain cancer	0.00192	0.00624	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00185	0.00603	CcSEcCtD
Sitagliptin—Breast disorder—Temozolomide—brain cancer	0.00179	0.00584	CcSEcCtD
Sitagliptin—Cough—Procarbazine—brain cancer	0.00173	0.00562	CcSEcCtD
Sitagliptin—Hypertension—Procarbazine—brain cancer	0.00171	0.00556	CcSEcCtD
Sitagliptin—Myalgia—Procarbazine—brain cancer	0.00168	0.00548	CcSEcCtD
Sitagliptin—Arthralgia—Procarbazine—brain cancer	0.00168	0.00548	CcSEcCtD
Sitagliptin—Anxiety—Procarbazine—brain cancer	0.00168	0.00546	CcSEcCtD
Sitagliptin—Bronchitis—Temozolomide—brain cancer	0.00165	0.00537	CcSEcCtD
Sitagliptin—Dry mouth—Procarbazine—brain cancer	0.00165	0.00536	CcSEcCtD
Sitagliptin—Vomiting—Lomustine—brain cancer	0.00162	0.00526	CcSEcCtD
Sitagliptin—Infection—Procarbazine—brain cancer	0.0016	0.00522	CcSEcCtD
Sitagliptin—Hyperglycaemia—Carmustine—brain cancer	0.0016	0.00522	CcSEcCtD
Sitagliptin—Angiopathy—Hydroxyurea—brain cancer	0.00159	0.00519	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Temozolomide—brain cancer	0.00159	0.00519	CcSEcCtD
Sitagliptin—Pneumonia—Carmustine—brain cancer	0.00159	0.00519	CcSEcCtD
Sitagliptin—Erectile dysfunction—Temozolomide—brain cancer	0.00158	0.00515	CcSEcCtD
Sitagliptin—Depression—Carmustine—brain cancer	0.00158	0.00514	CcSEcCtD
Sitagliptin—Weight increased—Temozolomide—brain cancer	0.00156	0.00509	CcSEcCtD
Sitagliptin—Renal failure—Carmustine—brain cancer	0.00156	0.00507	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Carmustine—brain cancer	0.00155	0.00505	CcSEcCtD
Sitagliptin—Hyperglycaemia—Temozolomide—brain cancer	0.00155	0.00504	CcSEcCtD
Sitagliptin—Urinary tract infection—Carmustine—brain cancer	0.00154	0.00501	CcSEcCtD
Sitagliptin—Pneumonia—Temozolomide—brain cancer	0.00154	0.00501	CcSEcCtD
Sitagliptin—Infestation—Temozolomide—brain cancer	0.00153	0.00498	CcSEcCtD
Sitagliptin—Infestation NOS—Temozolomide—brain cancer	0.00153	0.00498	CcSEcCtD
Sitagliptin—Depression—Temozolomide—brain cancer	0.00153	0.00497	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00152	0.00494	CcSEcCtD
Sitagliptin—Nausea—Lomustine—brain cancer	0.00151	0.00492	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Temozolomide—brain cancer	0.0015	0.00488	CcSEcCtD
Sitagliptin—Urinary tract infection—Temozolomide—brain cancer	0.00149	0.00484	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00147	0.00479	CcSEcCtD
Sitagliptin—Insomnia—Procarbazine—brain cancer	0.00146	0.00475	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Temozolomide—brain cancer	0.00145	0.00471	CcSEcCtD
Sitagliptin—Sinusitis—Temozolomide—brain cancer	0.00144	0.00467	CcSEcCtD
Sitagliptin—Somnolence—Procarbazine—brain cancer	0.00143	0.00467	CcSEcCtD
Sitagliptin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00142	0.00462	CcSEcCtD
Sitagliptin—Hypoaesthesia—Carmustine—brain cancer	0.00141	0.00461	CcSEcCtD
Sitagliptin—Decreased appetite—Procarbazine—brain cancer	0.0014	0.00457	CcSEcCtD
Sitagliptin—Oedema peripheral—Carmustine—brain cancer	0.0014	0.00456	CcSEcCtD
Sitagliptin—Connective tissue disorder—Carmustine—brain cancer	0.0014	0.00455	CcSEcCtD
Sitagliptin—Fatigue—Procarbazine—brain cancer	0.00139	0.00453	CcSEcCtD
Sitagliptin—Malaise—Hydroxyurea—brain cancer	0.00138	0.00449	CcSEcCtD
Sitagliptin—Pain—Procarbazine—brain cancer	0.00138	0.00449	CcSEcCtD
Sitagliptin—Constipation—Procarbazine—brain cancer	0.00138	0.00449	CcSEcCtD
Sitagliptin—Hypoaesthesia—Temozolomide—brain cancer	0.00137	0.00445	CcSEcCtD
Sitagliptin—Pharyngitis—Temozolomide—brain cancer	0.00136	0.00444	CcSEcCtD
Sitagliptin—Urinary tract disorder—Temozolomide—brain cancer	0.00136	0.00442	CcSEcCtD
Sitagliptin—Oedema peripheral—Temozolomide—brain cancer	0.00135	0.00441	CcSEcCtD
Sitagliptin—Connective tissue disorder—Temozolomide—brain cancer	0.00135	0.0044	CcSEcCtD
Sitagliptin—Urethral disorder—Temozolomide—brain cancer	0.00135	0.00438	CcSEcCtD
Sitagliptin—Feeling abnormal—Procarbazine—brain cancer	0.00133	0.00433	CcSEcCtD
Sitagliptin—Eye disorder—Carmustine—brain cancer	0.00133	0.00433	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Procarbazine—brain cancer	0.00132	0.0043	CcSEcCtD
Sitagliptin—Erythema multiforme—Temozolomide—brain cancer	0.0013	0.00423	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00129	0.00421	CcSEcCtD
Sitagliptin—Discomfort—Hydroxyurea—brain cancer	0.00129	0.00419	CcSEcCtD
Sitagliptin—Eye disorder—Temozolomide—brain cancer	0.00128	0.00418	CcSEcCtD
Sitagliptin—Urticaria—Procarbazine—brain cancer	0.00128	0.00418	CcSEcCtD
Sitagliptin—Abdominal pain—Procarbazine—brain cancer	0.00128	0.00415	CcSEcCtD
Sitagliptin—Cardiac disorder—Temozolomide—brain cancer	0.00127	0.00415	CcSEcCtD
Sitagliptin—Angiopathy—Temozolomide—brain cancer	0.00125	0.00406	CcSEcCtD
Sitagliptin—Mental disorder—Carmustine—brain cancer	0.00125	0.00405	CcSEcCtD
Sitagliptin—Infection—Hydroxyurea—brain cancer	0.00124	0.00404	CcSEcCtD
Sitagliptin—Immune system disorder—Temozolomide—brain cancer	0.00124	0.00404	CcSEcCtD
Sitagliptin—Mediastinal disorder—Temozolomide—brain cancer	0.00124	0.00403	CcSEcCtD
Sitagliptin—Malnutrition—Carmustine—brain cancer	0.00124	0.00403	CcSEcCtD
Sitagliptin—Pneumonia—Etoposide—brain cancer	0.00123	0.00401	CcSEcCtD
Sitagliptin—Nervous system disorder—Hydroxyurea—brain cancer	0.00122	0.00399	CcSEcCtD
Sitagliptin—Infestation—Etoposide—brain cancer	0.00122	0.00399	CcSEcCtD
Sitagliptin—Infestation NOS—Etoposide—brain cancer	0.00122	0.00399	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00121	0.00395	CcSEcCtD
Sitagliptin—Skin disorder—Hydroxyurea—brain cancer	0.00121	0.00395	CcSEcCtD
Sitagliptin—Renal failure—Etoposide—brain cancer	0.0012	0.00392	CcSEcCtD
Sitagliptin—Mental disorder—Temozolomide—brain cancer	0.0012	0.00392	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Etoposide—brain cancer	0.0012	0.00391	CcSEcCtD
Sitagliptin—Back pain—Carmustine—brain cancer	0.0012	0.0039	CcSEcCtD
Sitagliptin—Malnutrition—Temozolomide—brain cancer	0.0012	0.00389	CcSEcCtD
Sitagliptin—Hypersensitivity—Procarbazine—brain cancer	0.00119	0.00387	CcSEcCtD
Sitagliptin—Vision blurred—Carmustine—brain cancer	0.00117	0.0038	CcSEcCtD
Sitagliptin—Asthenia—Procarbazine—brain cancer	0.00116	0.00377	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Etoposide—brain cancer	0.00116	0.00377	CcSEcCtD
Sitagliptin—Back pain—Temozolomide—brain cancer	0.00116	0.00377	CcSEcCtD
Sitagliptin—Vision blurred—Temozolomide—brain cancer	0.00113	0.00367	CcSEcCtD
Sitagliptin—Somnolence—Hydroxyurea—brain cancer	0.00111	0.00362	CcSEcCtD
Sitagliptin—Ill-defined disorder—Temozolomide—brain cancer	0.00111	0.00361	CcSEcCtD
Sitagliptin—Diarrhoea—Procarbazine—brain cancer	0.0011	0.0036	CcSEcCtD
Sitagliptin—Dyspepsia—Hydroxyurea—brain cancer	0.0011	0.00358	CcSEcCtD
Sitagliptin—Hypoaesthesia—Etoposide—brain cancer	0.00109	0.00356	CcSEcCtD
Sitagliptin—Angioedema—Temozolomide—brain cancer	0.00109	0.00356	CcSEcCtD
Sitagliptin—Decreased appetite—Hydroxyurea—brain cancer	0.00109	0.00354	CcSEcCtD
Sitagliptin—Urinary tract disorder—Etoposide—brain cancer	0.00109	0.00353	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00108	0.00351	CcSEcCtD
Sitagliptin—Malaise—Temozolomide—brain cancer	0.00108	0.00351	CcSEcCtD
Sitagliptin—Urethral disorder—Etoposide—brain cancer	0.00108	0.00351	CcSEcCtD
Sitagliptin—Fatigue—Hydroxyurea—brain cancer	0.00108	0.00351	CcSEcCtD
Sitagliptin—Vertigo—Temozolomide—brain cancer	0.00107	0.0035	CcSEcCtD
Sitagliptin—Hypertension—Carmustine—brain cancer	0.00107	0.00348	CcSEcCtD
Sitagliptin—Pain—Hydroxyurea—brain cancer	0.00107	0.00348	CcSEcCtD
Sitagliptin—Constipation—Hydroxyurea—brain cancer	0.00107	0.00348	CcSEcCtD
Sitagliptin—Dizziness—Procarbazine—brain cancer	0.00107	0.00348	CcSEcCtD
Sitagliptin—Myalgia—Carmustine—brain cancer	0.00105	0.00343	CcSEcCtD
Sitagliptin—Anxiety—Carmustine—brain cancer	0.00105	0.00342	CcSEcCtD
Sitagliptin—Cough—Temozolomide—brain cancer	0.00104	0.0034	CcSEcCtD
Sitagliptin—Erythema multiforme—Etoposide—brain cancer	0.00104	0.00338	CcSEcCtD
Sitagliptin—Hypertension—Temozolomide—brain cancer	0.00103	0.00336	CcSEcCtD
Sitagliptin—Feeling abnormal—Hydroxyurea—brain cancer	0.00103	0.00335	CcSEcCtD
Sitagliptin—Eye disorder—Etoposide—brain cancer	0.00103	0.00334	CcSEcCtD
Sitagliptin—Vomiting—Procarbazine—brain cancer	0.00103	0.00334	CcSEcCtD
Sitagliptin—Cardiac disorder—Etoposide—brain cancer	0.00102	0.00332	CcSEcCtD
Sitagliptin—Arthralgia—Temozolomide—brain cancer	0.00102	0.00331	CcSEcCtD
Sitagliptin—Myalgia—Temozolomide—brain cancer	0.00102	0.00331	CcSEcCtD
Sitagliptin—Rash—Procarbazine—brain cancer	0.00102	0.00331	CcSEcCtD
Sitagliptin—Dermatitis—Procarbazine—brain cancer	0.00102	0.00331	CcSEcCtD
Sitagliptin—Anxiety—Temozolomide—brain cancer	0.00101	0.0033	CcSEcCtD
Sitagliptin—Headache—Procarbazine—brain cancer	0.00101	0.00329	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00101	0.00329	CcSEcCtD
Sitagliptin—Discomfort—Temozolomide—brain cancer	0.00101	0.00328	CcSEcCtD
Sitagliptin—Infection—Carmustine—brain cancer	0.001	0.00327	CcSEcCtD
Sitagliptin—Angiopathy—Etoposide—brain cancer	0.000997	0.00325	CcSEcCtD
Sitagliptin—Dry mouth—Temozolomide—brain cancer	0.000995	0.00324	CcSEcCtD
Sitagliptin—Immune system disorder—Etoposide—brain cancer	0.000993	0.00323	CcSEcCtD
Sitagliptin—Mediastinal disorder—Etoposide—brain cancer	0.00099	0.00323	CcSEcCtD
Sitagliptin—Anaphylactic shock—Temozolomide—brain cancer	0.000976	0.00318	CcSEcCtD
Sitagliptin—Infection—Temozolomide—brain cancer	0.000969	0.00316	CcSEcCtD
Sitagliptin—Nausea—Procarbazine—brain cancer	0.000959	0.00312	CcSEcCtD
Sitagliptin—Nervous system disorder—Temozolomide—brain cancer	0.000957	0.00312	CcSEcCtD
Sitagliptin—Skin disorder—Temozolomide—brain cancer	0.000948	0.00309	CcSEcCtD
Sitagliptin—Back pain—Etoposide—brain cancer	0.000925	0.00301	CcSEcCtD
Sitagliptin—Hypersensitivity—Hydroxyurea—brain cancer	0.00092	0.003	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Carmustine—brain cancer	0.00092	0.003	CcSEcCtD
Sitagliptin—Muscle spasms—Etoposide—brain cancer	0.00092	0.003	CcSEcCtD
Sitagliptin—Insomnia—Carmustine—brain cancer	0.000913	0.00297	CcSEcCtD
Sitagliptin—Somnolence—Carmustine—brain cancer	0.000898	0.00292	CcSEcCtD
Sitagliptin—Asthenia—Hydroxyurea—brain cancer	0.000896	0.00292	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000889	0.0029	CcSEcCtD
Sitagliptin—Ill-defined disorder—Etoposide—brain cancer	0.000888	0.00289	CcSEcCtD
Sitagliptin—Insomnia—Temozolomide—brain cancer	0.000882	0.00287	CcSEcCtD
Sitagliptin—Decreased appetite—Carmustine—brain cancer	0.000878	0.00286	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Carmustine—brain cancer	0.000872	0.00284	CcSEcCtD
Sitagliptin—Somnolence—Temozolomide—brain cancer	0.000867	0.00282	CcSEcCtD
Sitagliptin—Constipation—Carmustine—brain cancer	0.000863	0.00281	CcSEcCtD
Sitagliptin—Pain—Carmustine—brain cancer	0.000863	0.00281	CcSEcCtD
Sitagliptin—Malaise—Etoposide—brain cancer	0.000863	0.00281	CcSEcCtD
Sitagliptin—Vertigo—Etoposide—brain cancer	0.000859	0.0028	CcSEcCtD
Sitagliptin—Dyspepsia—Temozolomide—brain cancer	0.000859	0.0028	CcSEcCtD
Sitagliptin—Diarrhoea—Hydroxyurea—brain cancer	0.000855	0.00278	CcSEcCtD
Sitagliptin—Decreased appetite—Temozolomide—brain cancer	0.000848	0.00276	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000842	0.00274	CcSEcCtD
Sitagliptin—Fatigue—Temozolomide—brain cancer	0.000841	0.00274	CcSEcCtD
Sitagliptin—Cough—Etoposide—brain cancer	0.000835	0.00272	CcSEcCtD
Sitagliptin—Constipation—Temozolomide—brain cancer	0.000834	0.00272	CcSEcCtD
Sitagliptin—Pain—Temozolomide—brain cancer	0.000834	0.00272	CcSEcCtD
Sitagliptin—Feeling abnormal—Carmustine—brain cancer	0.000832	0.00271	CcSEcCtD
Sitagliptin—Hypertension—Etoposide—brain cancer	0.000826	0.00269	CcSEcCtD
Sitagliptin—Dizziness—Hydroxyurea—brain cancer	0.000826	0.00269	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Carmustine—brain cancer	0.000826	0.00269	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000809	0.00263	CcSEcCtD
Sitagliptin—Discomfort—Etoposide—brain cancer	0.000805	0.00262	CcSEcCtD
Sitagliptin—Feeling abnormal—Temozolomide—brain cancer	0.000804	0.00262	CcSEcCtD
Sitagliptin—Abdominal pain—Carmustine—brain cancer	0.000798	0.0026	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Temozolomide—brain cancer	0.000798	0.0026	CcSEcCtD
Sitagliptin—Vomiting—Hydroxyurea—brain cancer	0.000794	0.00259	CcSEcCtD
Sitagliptin—Rash—Hydroxyurea—brain cancer	0.000787	0.00256	CcSEcCtD
Sitagliptin—Dermatitis—Hydroxyurea—brain cancer	0.000787	0.00256	CcSEcCtD
Sitagliptin—Headache—Hydroxyurea—brain cancer	0.000782	0.00255	CcSEcCtD
Sitagliptin—Anaphylactic shock—Etoposide—brain cancer	0.000781	0.00254	CcSEcCtD
Sitagliptin—Infection—Etoposide—brain cancer	0.000776	0.00253	CcSEcCtD
Sitagliptin—Urticaria—Temozolomide—brain cancer	0.000775	0.00252	CcSEcCtD
Sitagliptin—Abdominal pain—Temozolomide—brain cancer	0.000771	0.00251	CcSEcCtD
Sitagliptin—Skin disorder—Etoposide—brain cancer	0.000758	0.00247	CcSEcCtD
Sitagliptin—Hypersensitivity—Carmustine—brain cancer	0.000744	0.00242	CcSEcCtD
Sitagliptin—Nausea—Hydroxyurea—brain cancer	0.000742	0.00242	CcSEcCtD
Sitagliptin—Asthenia—Carmustine—brain cancer	0.000724	0.00236	CcSEcCtD
Sitagliptin—Hypersensitivity—Temozolomide—brain cancer	0.000719	0.00234	CcSEcCtD
Sitagliptin—Asthenia—Temozolomide—brain cancer	0.0007	0.00228	CcSEcCtD
Sitagliptin—Somnolence—Etoposide—brain cancer	0.000694	0.00226	CcSEcCtD
Sitagliptin—Diarrhoea—Carmustine—brain cancer	0.000691	0.00225	CcSEcCtD
Sitagliptin—Decreased appetite—Etoposide—brain cancer	0.000679	0.00221	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Etoposide—brain cancer	0.000674	0.0022	CcSEcCtD
Sitagliptin—Fatigue—Etoposide—brain cancer	0.000673	0.00219	CcSEcCtD
Sitagliptin—Dizziness—Carmustine—brain cancer	0.000668	0.00217	CcSEcCtD
Sitagliptin—Pain—Etoposide—brain cancer	0.000668	0.00217	CcSEcCtD
Sitagliptin—Constipation—Etoposide—brain cancer	0.000668	0.00217	CcSEcCtD
Sitagliptin—Diarrhoea—Temozolomide—brain cancer	0.000668	0.00217	CcSEcCtD
Sitagliptin—Dizziness—Temozolomide—brain cancer	0.000645	0.0021	CcSEcCtD
Sitagliptin—Feeling abnormal—Etoposide—brain cancer	0.000643	0.0021	CcSEcCtD
Sitagliptin—Vomiting—Carmustine—brain cancer	0.000642	0.00209	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Etoposide—brain cancer	0.000638	0.00208	CcSEcCtD
Sitagliptin—Rash—Carmustine—brain cancer	0.000637	0.00207	CcSEcCtD
Sitagliptin—Dermatitis—Carmustine—brain cancer	0.000636	0.00207	CcSEcCtD
Sitagliptin—Headache—Carmustine—brain cancer	0.000633	0.00206	CcSEcCtD
Sitagliptin—Vomiting—Temozolomide—brain cancer	0.00062	0.00202	CcSEcCtD
Sitagliptin—Urticaria—Etoposide—brain cancer	0.00062	0.00202	CcSEcCtD
Sitagliptin—Abdominal pain—Etoposide—brain cancer	0.000617	0.00201	CcSEcCtD
Sitagliptin—Rash—Temozolomide—brain cancer	0.000615	0.002	CcSEcCtD
Sitagliptin—Dermatitis—Temozolomide—brain cancer	0.000615	0.002	CcSEcCtD
Sitagliptin—Headache—Temozolomide—brain cancer	0.000611	0.00199	CcSEcCtD
Sitagliptin—Nausea—Carmustine—brain cancer	0.0006	0.00195	CcSEcCtD
Sitagliptin—Nausea—Temozolomide—brain cancer	0.00058	0.00189	CcSEcCtD
Sitagliptin—Hypersensitivity—Etoposide—brain cancer	0.000575	0.00187	CcSEcCtD
Sitagliptin—Asthenia—Etoposide—brain cancer	0.00056	0.00182	CcSEcCtD
Sitagliptin—Diarrhoea—Etoposide—brain cancer	0.000534	0.00174	CcSEcCtD
Sitagliptin—Dizziness—Etoposide—brain cancer	0.000516	0.00168	CcSEcCtD
Sitagliptin—Vomiting—Etoposide—brain cancer	0.000496	0.00162	CcSEcCtD
Sitagliptin—Rash—Etoposide—brain cancer	0.000492	0.0016	CcSEcCtD
Sitagliptin—Dermatitis—Etoposide—brain cancer	0.000492	0.0016	CcSEcCtD
Sitagliptin—Headache—Etoposide—brain cancer	0.000489	0.00159	CcSEcCtD
Sitagliptin—Nausea—Etoposide—brain cancer	0.000464	0.00151	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.000288	0.114	CbGpPWpGaD
Sitagliptin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000259	0.103	CbGpPWpGaD
Sitagliptin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000235	0.0933	CbGpPWpGaD
Sitagliptin—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.0002	0.0795	CbGpPWpGaD
Sitagliptin—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000124	0.0493	CbGpPWpGaD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—brain cancer	0.000122	0.0484	CbGpPWpGaD
Sitagliptin—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00012	0.0474	CbGpPWpGaD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—brain cancer	0.000109	0.043	CbGpPWpGaD
Sitagliptin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	7.43e-05	0.0295	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	7.08e-05	0.0281	CbGpPWpGaD
Sitagliptin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	6.67e-05	0.0264	CbGpPWpGaD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	6.42e-05	0.0254	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	5.97e-05	0.0237	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	5.16e-05	0.0205	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	5.09e-05	0.0202	CbGpPWpGaD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	4.58e-05	0.0182	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	4.36e-05	0.0173	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	4.18e-05	0.0166	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—CTNNB1—brain cancer	3.68e-05	0.0146	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	2.9e-05	0.0115	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	2.77e-05	0.011	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	2.73e-05	0.0108	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	2.58e-05	0.0102	CbGpPWpGaD
Sitagliptin—CYP3A4—Irinotecan Pathway—APC—brain cancer	2.35e-05	0.00933	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	2.25e-05	0.0089	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP2C9—brain cancer	2.22e-05	0.00881	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	2.19e-05	0.00869	CbGpPWpGaD
Sitagliptin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	2.09e-05	0.00827	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	1.81e-05	0.00717	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	1.23e-05	0.00489	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	1.19e-05	0.00473	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	1.18e-05	0.00466	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	1.03e-05	0.00408	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	9.75e-06	0.00387	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.53e-06	0.00338	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	8.53e-06	0.00338	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	8.23e-06	0.00326	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	7.71e-06	0.00306	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CTNNB1—brain cancer	6.95e-06	0.00276	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	6.76e-06	0.00268	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL2—brain cancer	6.73e-06	0.00267	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	6.63e-06	0.00263	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	6.61e-06	0.00262	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	6.55e-06	0.0026	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.24e-06	0.00247	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	6.09e-06	0.00241	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	5.8e-06	0.0023	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—brain cancer	5.72e-06	0.00227	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	5.01e-06	0.00199	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.72e-06	0.00187	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.94e-06	0.00156	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP2C9—brain cancer	3.8e-06	0.00151	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.67e-06	0.00145	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP2C9—brain cancer	3.31e-06	0.00131	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.24e-06	0.00128	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—BSG—brain cancer	3.23e-06	0.00128	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.21e-06	0.00127	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.82e-06	0.00112	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—BSG—brain cancer	2.82e-06	0.00112	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—IDH1—brain cancer	2.78e-06	0.0011	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.6e-06	0.00103	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.54e-06	0.00101	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—IDH1—brain cancer	2.42e-06	0.00096	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.26e-06	0.000897	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ENO2—brain cancer	2.2e-06	0.000871	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.13e-06	0.000846	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP2C9—brain cancer	2.04e-06	0.000809	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ENO2—brain cancer	1.91e-06	0.000759	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—BSG—brain cancer	1.73e-06	0.000688	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—IDH1—brain cancer	1.49e-06	0.000591	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ENO2—brain cancer	1.18e-06	0.000467	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CG—brain cancer	1.01e-06	0.0004	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CG—brain cancer	8.78e-07	0.000348	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CG—brain cancer	5.41e-07	0.000214	CbGpPWpGaD
